Coagulation protein disease

Part of

Sub-types of Coagulation protein disease

• Hemophilia 55 trials · 214 incl. sub-types
  4 sub-types

  • Hemophilia A 178 trials Sub-types →
  • Hemophilia B 84 trials · 91 incl. sub-types Sub-types →
  • Acquired hemophilia 2 trials · 7 incl. sub-types Sub-types →
  • Factor XI deficiency 0 trials Sub-types →
• Von Willebrand disease (hereditary or acquired) 39 trials · 46 incl. sub-types
  2 sub-types

  • Hereditary von Willebrand disease 18 trials · 29 incl. sub-types Sub-types →
  • Acquired von willebrand syndrome 3 trials
• Acquired coagulation factor deficiency 4 trials · 15 incl. sub-types
  6 sub-types

  • Acquired hemophilia 2 trials · 7 incl. sub-types Sub-types →
  • Acquired von willebrand syndrome 3 trials
  • Acquired factor X deficiency 1 trial
  • Acquired factor V deficiency 0 trials
  • Acquired factor VII deficiency 0 trials
  • Acquired factor XIII deficiency 0 trials
• Factor VII deficiency 6 trials
  2 sub-types

  • Congenital factor VII deficiency 3 trials
  • Acquired factor VII deficiency 0 trials
• Congenital fibrinogen deficiency 2 trials · 6 incl. sub-types
  1 sub-type

  • Familial dysfibrinogenemia 2 trials · 6 incl. sub-types Sub-types →
• Thrombophilia due to activated protein C resistance 5 trials
• Congenital vitamin K-dependent coagulation factors deficiency 0 trials · 4 incl. sub-types
  5 sub-types

  • Congenital factor VII deficiency 3 trials
  • Vitamin K-dependent clotting factors, combined deficiency of, type 1 1 trial
  • Congenital factor X deficiency 0 trials
  • Congenital prothrombin deficiency 0 trials
  • Vitamin K-dependent clotting factors, combined deficiency of, type 2 0 trials
• Factor X deficiency 2 trials
  2 sub-types

  • Acquired factor X deficiency 1 trial
  • Congenital factor X deficiency 0 trials
• Congenital factor XII deficiency 1 trial
• Congenital plasminogen activator inhibitor type 1 deficiency 1 trial
• Hypoplasminogenemia 1 trial
• East Texas bleeding disorder 0 trials
• Tatsumi factor deficiency 0 trials
• Alpha-2-plasmin inhibitor deficiency 0 trials
• Combined deficiency of factor V and factor VIII 0 trials
  3 sub-types

  • Factor 5 and Factor VIII, combined deficiency of, 2 0 trials
  • Factor V and factor VIII, combined deficiency of, type 1 0 trials
  • Factor V and factor VIII, combined deficiency of, with normal protein C and protein C inhibitor 0 trials
• Combined deficiency of factor VII and factor X 0 trials
• Congenital high-molecular-weight kininogen deficiency 0 trials
• Dysplasminogenemia 0 trials
• Factor V amsterdam bleeding disorder 0 trials
• Factor V atlanta bleeding disorder 0 trials
• Factor V deficiency 0 trials
  2 sub-types

  • Acquired factor V deficiency 0 trials
  • Congenital factor V deficiency 0 trials
• Factor V short isoforms-related bleeding disorder 0 trials
• Factor XIII deficiency 0 trials
  2 sub-types

  • Acquired factor XIII deficiency 0 trials
  • Congenital factor XIII deficiency 0 trials Sub-types →
• Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation 0 trials
• Inherited prekallikrein deficiency 0 trials
• Multiple sclerosis-ichthyosis-factor VIII deficiency syndrome 0 trials
• Plasminogen deficiency, type II 0 trials
• Thrombomodulin-related bleeding disorder 0 trials